Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PHAR

Pharming Group N.V.

Healthcare · USD

Set alert

Price alert · PHAR

All alert types
12.23 USD -0.01 -0.10%
As of Oct 30, 2026 Extended hours 12.23 0.00%
Bid
11.56 × 1
Ask
12.26 × 1
12.09 Day range 12.31
9.11 52-week range 21.18
YTD
-30.79%
1 year
-6.93%
Open
12.18
Prev close
12.24
Mkt cap
865.62M
Vol
14.05K
Avg vol
24.59K
EPS
0.32
P/E
38.22
Div yield
0.00%
More statistics
Low
12.09
High
12.31
Forward P/E
216.49
Beta
0.09
Short ratio
0.38
Inst. own
0.14%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
13.57
200-d avg
15.63
1y target
34.35

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for PHAR has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.10 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 2
  • P/E 2
  • P/B 3

Valuation

P/E 442×
FY 2016: -45.1×FY 2017: -9.3×FY 2018: 41.4×FY 2019: 28.6×FY 2020: 26.3×FY 2021: 39.4×FY 2022: 66.4×FY 2023: -78.8×FY 2024: -57.2×FY 2025: 442×
FY 2016 5y median 39.4× FY 2025
P/S 3.4×
FY 2016: 49.3×FY 2017: 8.1×FY 2018: 7.7×FY 2019: 6.6×FY 2020: 4.7×FY 2021: 3.9×FY 2022: 4.4×FY 2023: 3.1×FY 2024: 2.3×FY 2025: 3.4×
FY 2016 5y median 3.4× FY 2025
P/B 4.5×
FY 2016: 30.0×FY 2017: 54.0×FY 2018: 19.3×FY 2019: 10.7×FY 2020: 6.6×FY 2021: 3.6×FY 2022: 4.4×FY 2023: 3.4×FY 2024: 3.0×FY 2025: 4.5×
FY 2016 5y median 3.6× FY 2025
P/FCF 23.4×
FY 2016: -68.0×FY 2017: 22.5×FY 2018: 28.3×FY 2019: 25.7×FY 2020: 14.5×FY 2021: 37.1×FY 2022: 44.5×FY 2023: -40.0×FY 2024: -268×FY 2025: 23.4×
FY 2016 5y median 23.4× FY 2025
EV/EBITDA 35.4×
FY 2016: -61.8×FY 2017: -11.6×FY 2018: 48.0×FY 2019: 17.3×FY 2020: 16.4×FY 2021: 15.4×FY 2022: 25.9×FY 2023: 87.1×FY 2024: 46.2×FY 2025: 35.4×
FY 2016 5y median 35.4× FY 2025
EV/Sales 3.3×
FY 2016: 51.4×FY 2017: 8.2×FY 2018: 7.7×FY 2019: 6.5×FY 2020: 4.5×FY 2021: 3.8×FY 2022: 4.2×FY 2023: 3.5×FY 2024: 2.5×FY 2025: 3.3×
FY 2016 5y median 3.5× FY 2025
FCF Yield 4.3%
FY 2016: -1.5%FY 2017: 4.4%FY 2018: 3.5%FY 2019: 3.9%FY 2020: 6.9%FY 2021: 2.7%FY 2022: 2.2%FY 2023: -2.5%FY 2024: -0.4%FY 2025: 4.3%
FY 2016 5y median 2.2% FY 2025

Profitability

Gross Margin 87.9%
FY 2016: 70.5%FY 2017: 86.1%FY 2018: 83.6%FY 2019: 87.4%FY 2020: 88.9%FY 2021: 89.4%FY 2022: 91.5%FY 2023: 89.7%FY 2024: 88.1%FY 2025: 87.9%
FY 2016 5y median 89.4% FY 2025
Operating Margin 5.6%
FY 2016: -72.7%FY 2017: 24.4%FY 2018: 28.1%FY 2019: 36.0%FY 2020: 35.9%FY 2021: 9.6%FY 2022: 4.8%FY 2023: -9.1%FY 2024: -1.2%FY 2025: 5.6%
FY 2016 5y median 4.8% FY 2025
Net Margin 0.8%
FY 2016: -110.5%FY 2017: -85.1%FY 2018: 18.5%FY 2019: 21.4%FY 2020: 17.8%FY 2021: 8.0%FY 2022: 6.7%FY 2023: -4.3%FY 2024: -4.0%FY 2025: 0.8%
FY 2016 5y median 0.8% FY 2025
ROE 1.0%
FY 2016: -67.1%FY 2017: -567.8%FY 2018: 46.3%FY 2019: 34.5%FY 2020: 25.1%FY 2021: 7.3%FY 2022: 6.7%FY 2023: -4.8%FY 2024: -5.2%FY 2025: 1.0%
FY 2016 5y median 1.0% FY 2025
ROIC 1.0%
FY 2016: -11.5%FY 2017: 15.4%FY 2018: 25.2%FY 2019: 27.1%FY 2020: 23.1%FY 2021: 3.3%FY 2022: 2.4%FY 2023: -5.0%FY 2024: -1.1%FY 2025: 1.0%
FY 2016 5y median 1.0% FY 2025
ROA 0.6%
FY 2016: -13.8%FY 2017: -45.9%FY 2018: 13.3%FY 2019: 15.8%FY 2020: 11.0%FY 2021: 3.6%FY 2022: 3.2%FY 2023: -2.3%FY 2024: -2.9%FY 2025: 0.6%
FY 2016 5y median 0.6% FY 2025

Growth (YoY)

Revenue 26.6%
FY 2016: 41.0%FY 2017: 544.1%FY 2018: 43.8%FY 2019: 22.5%FY 2020: 12.0%FY 2021: -6.3%FY 2022: 3.4%FY 2023: 19.3%FY 2024: 21.1%FY 2025: 26.6%
FY 2016 FY 2025
Operating Income 669.7%
FY 2016: 13.5%FY 2017: 316.6%FY 2018: 65.3%FY 2019: 57.0%FY 2020: 11.7%FY 2021: -75.1%FY 2022: -48.1%FY 2023: -326.1%FY 2024: 83.6%FY 2025: 669.7%
FY 2016 FY 2025
EPS (diluted) 122.2%
FY 2016: -63.0%FY 2017: -326.1%FY 2018: 123.5%FY 2019: 36.4%FY 2020: -2.9%FY 2021: -55.2%FY 2022: -22.5%FY 2023: -189.5%FY 2024: -24.1%FY 2025: 122.2%
FY 2016 FY 2025
Free Cash Flow 2182.3%
FY 2016: 0.0%FY 2017: 418.6%FY 2018: 8.9%FY 2019: 15.9%FY 2020: 40.3%FY 2021: -69.1%FY 2022: -3.1%FY 2023: -191.6%FY 2024: 86.2%FY 2025: 2182.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.6×
FY 2016: 1.2×FY 2017: 1.5×FY 2018: 1.4×FY 2019: 1.0×FY 2020: 3.4×FY 2021: 5.3×FY 2022: 4.6×FY 2023: 4.1×FY 2024: 3.8×FY 2025: 2.6×
FY 2016 5y median 4.1× FY 2025
Quick Ratio 2.0×
FY 2016: 0.9×FY 2017: 1.2×FY 2018: 1.2×FY 2019: 0.9×FY 2020: 3.1×FY 2021: 4.7×FY 2022: 3.9×FY 2023: 3.3×FY 2024: 3.0×FY 2025: 2.0×
FY 2016 5y median 3.3× FY 2025
Debt / Equity 0.4×
FY 2016: 2.5×FY 2017: 5.1×FY 2018: 1.4×FY 2019: 0.5×FY 2020: 0.9×FY 2021: 0.8×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.5×FY 2025: 0.4×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA -0.9×
FY 2016: -2.4×FY 2017: -0.2×FY 2018: 0.1×FY 2019: -0.2×FY 2020: -0.6×FY 2021: -0.7×FY 2022: -1.2×FY 2023: 11.1×FY 2024: 3.6×FY 2025: -0.9×
FY 2016 5y median -0.7× FY 2025
Interest Coverage 1.9×
FY 2016: -1.9×FY 2017: 0.6×FY 2018: 2.7×FY 2019: 5.1×FY 2020: 7.4×FY 2021: 2.7×FY 2022: 1.8×FY 2023: -3.7×FY 2024: -0.4×FY 2025: 1.9×
FY 2016 5y median 1.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31